• Iron overload aggravates MDS pathophysiology; long-term outcomes after TPO-RA treatment in ITP; new insights into APL treatment outcomes by age and risk

  • 2025/01/09
  • 再生時間： 17 分
  • ポッドキャスト

Iron overload aggravates MDS pathophysiology; long-term outcomes after TPO-RA treatment in ITP; new insights into APL treatment outcomes by age and risk

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this week's episode we'll learn about the role of iron in myelodysplastic syndromes, or MDS. After that: long-term treatment outcomes in immune thrombocytopenia from the STOPAGO study. Finally, new insights into APL treatment outcomes and prognostic factors from the large-scale Harmony APL project which used ATRA-Arsenic combination therapy.

    Featured Articles:

    • Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study
    • Long-term follow-up of the STOPAGO study
    • Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
    続きを読む 一部表示

あらすじ・解説

In this week's episode we'll learn about the role of iron in myelodysplastic syndromes, or MDS. After that: long-term treatment outcomes in immune thrombocytopenia from the STOPAGO study. Finally, new insights into APL treatment outcomes and prognostic factors from the large-scale Harmony APL project which used ATRA-Arsenic combination therapy.

Featured Articles:

  • Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study
  • Long-term follow-up of the STOPAGO study
  • Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
続きを読む 一部表示

Iron overload aggravates MDS pathophysiology; long-term outcomes after TPO-RA treatment in ITP; new insights into APL treatment outcomes by age and riskに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。